Claudia Haferlach

Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib

B. Hanfstein, Michael Lauseker, R Hehlmann et al. · Haematologica · 2014 · 119 citations · Full text

Medicine, Hematology, Oncology +11

NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia

Brunangelo Falini, Cristina Mecucci, Giuseppe Saglio et al. · Haematologica · 2008 · 81 citations · Full text

Life Sciences, Genetics, Oncology +17

Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA

S. Schnittger, Ulrike Bacher, Claudia Haferlach et al. · Haematologica · 2011 · 74 citations · Full text

Medicine, Genetics, Hematology +17

Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases

Susanne Schnittger, Ulrike Bacher, Tamara Alpermann et al. · Haematologica · 2012 · 30 citations · Full text

Medicine, Genetics, Molecular Genetics +12

The idic(X)(q13) in myeloid malignancies: breakpoint clustering in segmental duplications and association with TET2 mutations

Kajsa Paulsson, Claudia Haferlach, Christa Fonatsch et al. · Human Molecular Genetics · 2010 · 30 citations · Full text

Life Sciences, Genetics, Hematology +17